Paper · 58041

Specific suppression of the immune response by HGG tolerant spleen cells. I. Parameters affecting the level of suppression.

Doyle MV and 2 others. J Immunol, 1976. Cited by 74 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Specific suppression of the immune response by HGG tolerant spleen cells. I. Parameters affecting the level of suppression. Papers, record 58041. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/58041

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Specific suppression of the immune response by HGG tolerant spleen cells. I. Parameters affecting the level of suppression.; PubMed
Journal: J Immunol; PubMed
Year: 1976; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/58041/; PubMed
The journal: https://conductscience.org/library/journal-index/2985117R; PubMed
Citations, by iCite: 74; iCite
Relative citation ratio, by iCite: 1.68; iCite
Revised in PubMed: 2021-12-03; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Doyle MV	M V
2	Parks DE	D E
3	Weigle WO	W O

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Immune Tolerance	Major topic
Immunity, Cellular	Major topic
Immunosuppression Therapy	Major topic
Spleen	Major topic
gamma-Globulins	Major topic
Animals
Antibody-Producing Cells
Epitopes
Humans
Immunization, Passive
Male
Mice
Mice, Inbred A
Time Factors
Turkey

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMID	Title	Journal	Year	In Papers	Source
17,494,756	Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.	Proc Natl Acad Sci U S A	2007	https://conductscience.org/library/papers/17494756	PubMed
8,666,892	CD4+ T cell activation and tolerance induction in B cell knockout mice.	J Exp Med	1996	https://conductscience.org/library/papers/8666892	PubMed
7,693,854	In vivo induction of tolerance in murine CD4+ cell subsets.	J Exp Med	1993	https://conductscience.org/library/papers/7693854	PubMed
6,446,426	Current perspectives on the cellular mechanisms of immunologic tolerance.	Clin Exp Immunol	1980	https://conductscience.org/library/papers/6446426	PubMed
6,445,868	Regulatory T-cell subpopulations in pregnancy. II. Evidence for suppressive activity of the late phase of MLR.	Immunology	1980	https://conductscience.org/library/papers/6445868	PubMed
6,417,259	Tolerance for self IG at the level of the Ly1+ T cell.	J Exp Med	1983	https://conductscience.org/library/papers/6417259	PubMed
6,232,678	Tolerance: facts and views--1983.	Surv Immunol Res	1984	https://conductscience.org/library/papers/6232678	PubMed
6,169,780	Cellular interactions in immune regulation. Hapten-specific suppression by non-T cells and T cell mediated reversal of suppression.	J Exp Med	1981	https://conductscience.org/library/papers/6169780	PubMed
2,425,408	Tolerance induction and maintenance in primed lymphocytes.	Surv Immunol Res	1985	https://conductscience.org/library/papers/2425408	PubMed
371,881	Facilitation reaction (enhancing antibodies and suppressor cells) and rejection reaction (sensitized cells) from the mother to the paternal antigens of the conceptus.	Clin Exp Immunol	1979	https://conductscience.org/library/papers/371881	PubMed

1 to 10 of 19

See all 19 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/58041

GET https://conductscience.org/api/papers/v1/58041/authors

API reference For AI assistants